Long-term follow-up of a neoadjuvant chemohormonal taxane-based phase II trial before radical prostatectomy in patients with non-mestastic high-risk prostate cancer (vol 100, pg 274, 2007)

被引：0
|
作者：
不详
机构：
来源：
BJU INTERNATIONAL | 2007年 / 100卷 / 02期
关键词：
D O I：
10.1111/j.1464-410X.2007.07094.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：480 / 480
页数：1
相关论文
共 50 条
  • [1] Long-term follow-up of a neoadjuvant chemohormonal taxane-based phase II trial before radical prostatectomy in patients with non-metastatic high-risk prostate cancer
    Prayer-Galetti, Tomaso
    Sacco, Emilio
    Pagano, Francesco
    Gardiman, Marina
    Cisternino, Antonio
    Betto, Giovanni
    Sperandio, Paolo
    BJU INTERNATIONAL, 2007, 100 (02) : 274 - 280
  • [2] Neoadjuvant chemohormonal taxane-based therapy before radical prostatectomy (RRP) in high-risk prostate cancer: 4.4 years' follow-up of a phase II trial
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 214 - 214
  • [3] Long-term oncological outcomes of a phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localised, high-risk prostate cancer
    Silberstein, Jonathan L.
    Poon, Stephen A.
    Sjoberg, Daniel D.
    Maschino, Alexandra C.
    Vickers, Andrew J.
    Bernie, Aaron
    Konety, Badrinath R.
    Kelly, W. Kevin
    Eastham, James A.
    BJU INTERNATIONAL, 2015, 116 (01) : 50 - 56
  • [4] Long-term oncologic outcomes of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localized, high-risk prostate cancer
    Silberstein, Jonathan L.
    Poon, Stephen A.
    Sjoberg, Daniel
    Vickers, Andrew J.
    Bernie, Aaron
    Konety, Badrinath R.
    Kelly, William Kevin
    Eastham, James Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [5] Long-Term Follow-Up of a Prospective Trial of Neoadjuvant Chemotherapy and Androgen Deprivation Followed by Prostatectomy and Adjuvant Radiation in High-Risk Prostate Cancer
    Kwok, Y.
    Snider, J. W.
    Engelman, A.
    Alexander, R. B.
    Amin, P. P.
    Hussain, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S443 - S444
  • [6] TESTOSTERONE REPLACEMENT THERAPY IN PATIENTS WITH HIGH RISK PROSTATE CANCER AFTER RADICAL PROSTATECTOMY: LONG-TERM FOLLOW-UP
    Pastuszak, Alexander W.
    Pearlman, Amy M.
    Sathyamoorthy, Kumaran
    Liu, Joceline S.
    Lipshultz, Larry I.
    Miles, Brian J.
    Khera, Mohit
    JOURNAL OF UROLOGY, 2012, 187 (04): : E603 - E603
  • [7] Phase II Trial of Neoadjuvant Docetaxel and Gefitinib Followed by Radical Prostatectomy in Patients With High-Risk, Locally Advanced Prostate Cancer
    Vulky, Jacqueline
    Porter, Christopher
    Isacson, Christina
    Vaughan, Matthew
    Klowski, Paul
    Picozzi, Vincent
    Corman, John
    CANCER, 2009, 115 (04) : 784 - 791
  • [8] A phase II trial of neoadjuvant docetaxel and estramustine followed by radical prostatectomy or radiation therapy for patients with high-risk prostate cancer
    Goyal, L. K.
    Ramsey, S. N.
    Godley, P.
    Pruthi, R.
    Wallen, E.
    Whang, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S362 - S362
  • [9] LONG-TERM FOLLOW-UP OF A PROSPECTIVE TRIAL OF TRIMODALITY THERAPY OF WEEKLY PACLITAXEL, RADIATION, AND ANDROGEN DEPRIVATION IN HIGH-RISK PROSTATE CANCER WITH OR WITHOUT PRIOR PROSTATECTOMY
    Hussain, Arif
    Wu, Yin
    Mirmiran, Alireza
    DiBiase, Steven
    Goloubeva, Olga
    Bridges, Benjamin
    Mannuel, Heather
    Engstrom, Christine
    Dawson, Nancy
    Amin, Pradip
    Kwok, Young
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (01): : 167 - 174
  • [10] Phase I Trial of Stereotactic Body Radiotherapy Neoadjuvant to Radical Prostatectomy for Patients with Unfavorable and High-Risk Non-Metastatic Prostate Cancer: Feasibility And Safety
    Nickols, N. G.
    Kishan, A. U.
    Kane, N.
    Diaz-Perez, S.
    Ganapathy, E.
    Nazarian, R.
    Felix, C.
    Mathis, C.
    Kwak, J. Y.
    Basehart, V.
    Zomorodian, N.
    King, C. R.
    Kupelian, P. A.
    Rettig, M.
    Steinberg, M. L.
    Cao, M.
    Knudsen, B.
    Schaue, D.
    Reiter, R. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E298 - E298
12345